Gold Reserve Provides Update on CITGO Sale Process Objections

Gold Reserve provides an update on the briefing on objections in the CITGO sale process. Various parties filed reply briefs in respect of the objections to the Special Master's Final Recommendation, including Crystallex International Corporation and Blackrock Financial Management, Inc. Gold Reserve cautions that forward-looking statements involve known and unknown risks and uncertainties that may cause actual events to differ from estimated outcomes.

Gold Reserve has provided an update on the latest developments in the CITGO sale process. Various parties, including Crystallex International Corporation and Blackrock Financial Management, Inc., have filed reply briefs in response to the objections raised against the Special Master's Final Recommendation. The briefs highlight the complexities and challenges involved in the sale process, which remains subject to ongoing legal and regulatory scrutiny.

The Special Master's Final Recommendation, issued earlier, had recommended a sale of CITGO to a consortium led by Petróleos de Venezuela, S.A. (PDVSA). However, objections were raised by several parties, including Crystallex and Blackrock, who sought to challenge the recommendation on various grounds. The reply briefs submitted by these parties aim to address the specific concerns and arguments raised in the objections.

Gold Reserve has cautioned investors and stakeholders that forward-looking statements involve known and unknown risks and uncertainties. The company emphasizes that actual events may differ from estimated outcomes due to a variety of factors, including regulatory changes, market conditions, and legal challenges.

As the process continues to unfold, investors and financial professionals should remain vigilant and monitor the developments closely. The sale of CITGO, if successful, could have significant implications for the energy sector and global markets. However, the challenges and uncertainties surrounding the process highlight the need for a cautious and informed approach to investing.

References:
[1] https://za.investing.com/news/analyst-ratings/guggenheim-lowers-acadia-healthcare-stock-price-target-on-medicaid-volume-concerns-93CH-3825669
[2] https://www.businesswire.com/news/home/20250805952975/en/Acadia-Healthcare-Reports-Second-Quarter-2025-Results